Recent cogent evidence has provided a link between SOX9 and cancer development and progression [14,15], and the upregulation of SOX9 has been observed in several types of solid tumors, including lung adenocarcinoma, breast carcinoma, colorectal cancer, and prostate cancer [6-9]. This evidence concerns the gene SOX9 and cancer.